tiprankstipranks
Advertisement
Advertisement

EWTX Stock Latest News

Edgewise Therapeutics price target raised to $55 from $45 at Evercore ISI
The FlyEdgewise Therapeutics price target raised to $55 from $45 at Evercore ISI
1d ago
EWTX
Edgewise Therapeutics Sells Muscular Dystrophy Assets to Servier
PremiumCompany Announcements
Edgewise Therapeutics Sells Muscular Dystrophy Assets to Servier
8d ago
8K
EWTX
Edgewise Therapeutics completes sale of sevasemten for up to $2.65B
PremiumThe Fly
Edgewise Therapeutics completes sale of sevasemten for up to $2.65B
8d ago
EWTX
Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4
PremiumThe Fly
Edgewise Therapeutics expects to initiate Phase 3 trial of EDG-7500 in Q4
8d ago
EWTX
Edgewise Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
Edgewise Therapeutics initiated with an Outperform at Oppenheimer
12d ago
EWTX
Edgewise Therapeutics price target raised to $51 from $41 at Guggenheim
PremiumThe FlyEdgewise Therapeutics price target raised to $51 from $41 at Guggenheim
15d ago
EWTX
Edgewise Therapeutics price target raised to $59 from $48 at RBC Capital
Premium
The Fly
Edgewise Therapeutics price target raised to $59 from $48 at RBC Capital
1M ago
EWTX
Edgewise Therapeutics price target raised to $32 from $20 at Goldman Sachs
Premium
The Fly
Edgewise Therapeutics price target raised to $32 from $20 at Goldman Sachs
1M ago
EWTX
Edgewise Therapeutics price target raised to $52 from $50 at Leerink
PremiumThe Fly
Edgewise Therapeutics price target raised to $52 from $50 at Leerink
1M ago
EWTX
Buy Rating Reiterated on Edgewise Therapeutics as Strong EDG-7500 Data and Asset Sale Support Cardiovascular Pipeline; $45 Price Target Unchanged
PremiumRatings
Buy Rating Reiterated on Edgewise Therapeutics as Strong EDG-7500 Data and Asset Sale Support Cardiovascular Pipeline; $45 Price Target Unchanged
1M ago
EWTX
Edgewise Therapeutics falls -9.9%
PremiumThe Fly
Edgewise Therapeutics falls -9.9%
1M ago
EWTX
Video: SpaceX cements $60B Cursor takeover
PremiumThe Fly
Video: SpaceX cements $60B Cursor takeover
1M ago
HUN
OLN
Edgewise Therapeutics down 25% at $26.55 after EDG-7500 trial update
PremiumThe FlyEdgewise Therapeutics down 25% at $26.55 after EDG-7500 trial update
1M ago
EWTX
Edgewise Therapeutics’ EDG-7500 shows improvements in cardiomyopathy
Premium
The Fly
Edgewise Therapeutics’ EDG-7500 shows improvements in cardiomyopathy
1M ago
EWTX
Edgewise Therapeutics Shareholders Back Board and Governance
Premium
Company Announcements
Edgewise Therapeutics Shareholders Back Board and Governance
2M ago
8K
EWTX
Edgewise Therapeutics price target raised to $53 from $45 at JPMorgan
PremiumThe Fly
Edgewise Therapeutics price target raised to $53 from $45 at JPMorgan
2M ago
EWTX
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago
AZN
BMY
Edgewise Therapeutics price target lowered to $48 from $50 at RBC Capital
PremiumThe Fly
Edgewise Therapeutics price target lowered to $48 from $50 at RBC Capital
2M ago
EWTX
Edgewise Therapeutics price target raised to $45 from $42 at H.C. Wainwright
PremiumThe Fly
Edgewise Therapeutics price target raised to $45 from $42 at H.C. Wainwright
2M ago
EWTX
Edgewise Gets Buy Rating as Servier Deal Funds Cardiovascular Pivot; $45 Price Target Reaffirmed
PremiumRatingsEdgewise Gets Buy Rating as Servier Deal Funds Cardiovascular Pivot; $45 Price Target Reaffirmed
2M ago
EWTX
Edgewise Therapeutics price target raised to $66 from $52 at Raymond James
Premium
The Fly
Edgewise Therapeutics price target raised to $66 from $52 at Raymond James
2M ago
EWTX
Edgewise Therapeutics deal ‘looks really strong,’ says Stifel
Premium
The Fly
Edgewise Therapeutics deal ‘looks really strong,’ says Stifel
2M ago
EWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >